|
| |
Image Results
Loading...
Loading...
XIBROM Pages on BioPortfolio:
|
BioPortfolio - Xibrom - InDepth
(http://www.bioportfolio.com/indepth/Xibrom.html) - Regularly Updated. ***. Resources from the NCBI used in this document, NCBI's standard disclaimer ...
http://www.bioportfolio.com/indepth/Xibrom.pdf...
|
BioPortfolio's Approved Drugs News by Tradename - W to Z
XIBROM ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_p...
|
BioPortfolio Limited The Fastest Growing Biotechnology Companies ...
Xibrom, Istalol, Bepotastine, Ecabet Sodium, Latanoprost and Iganidipine. collaborations with Senju 108. Vitrase commercialization outside the US 108 ...
http://www.bioportfolio.com/cgi-bin/acatalog/2223.html...
|
BioPortfolio - ISTA Pharmaceuticals - Profile
ISTA has three approved products, Xibrom™ (for the treatment of ocular ... IstalolŪ during Q3 2004, VitraseŪ during Q1 2005 and Xibrom™ during Q2 2005. ...
http://www.bioportfolio.com/biocorporate/24934-ISTA%25252525...
|
BioPortfolio - ISTA Pharmaceuticals
ISTA has three approved products, Xibrom™ (for the treatment of ocular ... We launched Istalol® during Q3 2004, Vitrase® during Q1 2005 and Xibrom™ during ...
http://www.bioportfolio.com/biocorporate/24934-ISTA_Pharmace...
|
BioPortfolio News: ISTA Pharmaceuticals, Inc. - ISTA ...
Bepreve(TM) (bepotastine besilate ophthalmic solution) 1.5%, Xibrom(TM) ( bromfenac ophthalmic solution) 0.09%, and Istalol® (timolol maleate ophthalmic
...
http://www.bioportfolio.com/news/ISTA-Pharmaceuticals-Highli...
|
BioPortfolio - Indepth Browse
... Pigmentosum | Xeroderma Pigmentosum Group D Protein | Xeromammography | Xerophthalmia | Xeroradiography | Xerostomia | Xerostomia | Xibrom | Xifaxan ...
http://www.bioportfolio.com/indepth/search/X.htm...
| Results from other life science and pharmaceutical sites:
XIBROM (bromfenac sodium) solution [ISTA Pharmaceuticals, Inc ...
Each mL of Xibrom contains 1.035 mg bromfenac sodium equivalent to 0.9 mg bromfenac free acid. Bromfenac sodium is designated chemically as sodium ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=8783...
|
FDA Approvals: HepaGam B, Xibrom, Proair HFA
28 Feb 2006 ... The FDA has approved hepatitis B immune globulin [human] injection (HepaGam B), a supplemental indication for bromfenac sodium ophthalmic ...
http://www.medscape.com/viewarticle/524530...
|
Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ...
OBJECTIVE: To evaluate the efficacy and ocular safety of bromfenac ophthalmic solution 0.09% (Xibrom) for the treatment of postoperative inflammation and ...
http://www.ncbi.nlm.nih.gov/pubmed/17445902...
|
ISTA says daily Xibrom eye drops met goal in study - Yahoo! Finance
26 Aug 2009 ... IRVINE, Calif. (AP) -- ISTA Pharmaceuticals Inc. on Wednesday reported successful late-stage clinical trial results for Xibrom QD, ...
http://biz.yahoo.com/ap/090826/us_ista_pharma_xibrom.html?.v...
|
FDA Approvals: Nexium IV, Zofran, Xibrom
7 Apr 2005 ... The FDA has approved an intravenous formulation of esomeprazole magnesium ( Nexium IV), an expanded indication for ondansetron HCl injection ...
http://www.medscape.com/viewarticle/502650...
|
Global experience with Xibrom (bromfenac ophthalmic solution) 0.09 ...
Global experience with Xibrom (bromfenac ophthalmic solution) 0.09%: the first twice-daily ophthalmic nonsteroidal anti-inflammatory drug. ...
http://www.ncbi.nlm.nih.gov/pubmed/17060789...
|
ISTA Pharmaceuticals Announces Phase III Results for Once-Daily ...
According to a preliminary analysis, integrated results for the two studies demonstrated Xibrom 0.09% QD achieved statistical significance in meeting the
...
http://www.prnewswire.com/news-releases/ista-pharmaceuticals...
|
Bromfenac - Wikipedia, the free encyclopedia
... discontinued and withdrawn from the US market'). Bromfenac is currently marketed in the US as an ophthalmic solution (brand name: ""Xibrom""). ...
http://en.wikipedia.org/wiki/Bromfenac...
|
ISTA Pharmaceuticals, Inc. Announces Positive Preliminary Phase 3 ...
Xibrom 0.09% QD achieved statistical significance in the study's primary ... Ltd . ISTA acquired U.S. marketing rights for Xibrom in 2002 and launched the ...
http://www.biospace.com/news_story.aspx?NewsEntityId=154065...
|
Summary of ISTA PHARMACEUTICALS INC - Yahoo! Finance
5 Nov 2009 ... We announced positive preliminary Phase 3 results from the Xibrom 0.09% QD confirmatory clinical study. Xibrom 0.09% QD achieved statistical ...
http://biz.yahoo.com/e/091105/ista10-q.html...
|
|
